V60 VENTILATOR
Report
- Report Number
- 2031642-2017-03162
- Event Type
- Injury
- Date Received
- October 3, 2017
- Date of Event
- September 14, 2017
- Report Date
- September 22, 2017
- Manufacturer
- RESPIRONICS CALIFORNIA, INC
- Product Code
- MNT
- UDI-DI
- 00884838025776
- PMA / PMN Number
- K082660
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
THE AUTHORIZED SERVICE PROVIDER, (B)(6), CONFIRMED THERE WERE NO FAILURES WITH THE VENTILATOR. IT WAS CONFIRMED THAT GASTRIC DILATION WAS A DESCRIBED SIDE EFFECT IN THE USER MANUAL. THE CLINICAL STAFF AT THE HOSPITAL WAS GIVEN FURTHER TRAINING ON THIS.
THE DETERMINATION COULD NOT BE MADE THAT THE DEVICE FAILED TO MEET SPECIFICATIONS. THE DEVICE WAS BEING USED FOR TREATMENT WHEN THE REPORTED EVENT OCCURRED, AND THERE IS A RELATIONSHIP OF THE DEVICE TO THE ADVERSE EVENT]. GASTRIC DISTENTION IS A KNOWN PATIENT ISSUE WITH POSITIVE PRESSURE VENTILATION.
A PHYSICIAN REPORTED THAT A PATIENT HAD GASTRIC DISTENTION. THE PATIENT WAS ADMITTED FOR ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, HEART DISEASE, TYPE 2 RESPIRATORY FAILURE, RESPIRATORY ACIDOSIS, METABOLIC ALKALOSIS AND HYPERPLASIA OF THE PROSTATE. THE PATIENT WAS ON THE VENTILATOR FOR APPROXIMATELY ONE WEEK FOR FOUR HOURS A DAY, AND ON (B)(6) 2017, HAD AIR LEAKAGE OF 7 20/L, THE PATIENT HAD FLATULENCE AND IT WAS VISIBLE. THE VENTILATOR WAS REMOVED AND THE PATIENT WAS TREATED WITH TONGLI SHENLING GRANULES 10 G FOR SPLEEN AND STOMACH THREE TIMES A DAY) AND DOMPERIDONE MALEATE TABS 12.7 MG. AFTER ONE WEEK OF TREATMENT THE PATIENT HAS NO FURTHER SYMPTOMS AND DID NOT REQUIRE A NASO-GASTRIC TUBE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 692067 | V60 VENTILATOR | VENTILATOR, CONTINUOUS, MINIMAL VENTILATORY SUPPORT,FACILITY USE | MNT | RESPIRONICS CALIFORNIA, INC | V60 | 00884838025776 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Required Intervention |